Skip to main content
Log in

Roles of MgO release from polyethylene glycol 6000-based solid dispersions on microenvironmental pH, enhanced dissolution and reduced gastrointestinal damage of telmisartan

  • Research Articles
  • Drug Development
  • Published:
Archives of Pharmacal Research Aims and scope Submit manuscript

Abstract

The roles of magnesium oxide (MgO) release from solid dispersions (SDs) in simulated gastric fluid (SGF), simulated intestinal fluid (SIF) and water were investigated to elucidate the enhanced dissolution and reduced intestinal damages of telmisartan as a model drug. The polyethylene glycol 6000 (PEG 6000) was used to prepare the SDs. Three SDs were prepared: SD1 (PEG, MgO, TEL), SD2 (PEG 6000, TEL), SD3 (MgO, TEL). The physical mixture (PM) consisting of SD2 and MgO was also prepared. A binary SD without MgO (SD2) was also prepared for comparison in microenvironmental pH (pHM) modulation. The faster MgO released, the less control of pHM and the less enhanced dissolution of TEL were in consequences. SD3 increased dissolution in SIF and water (about 67%). Interestingly, ternary SD1 showed almost complete dissolution in all three media but dissolution of PM was the lowest due to the fast release of MgO and poor modulation of pHM. MgO did not change the drug crystallinity but did have a strong molecular interaction with the drug. Additionally, the SD3-bearing tablet quickly increased pHM but then gradually decreased due to faster release of MgO while the SD1-bearing tablet gradually increased pHM at all fractional dimensions of the tablet by the MgO slowly released. The pHM of PM-bearing tablets was not varied as a function of time. Thus, the MgO-bearing SD1 also minimized gastrointestinal tissue damage caused by the model drug.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Chiou, W. L. and Riegelman, S., Pharmaceutical applications of solid dispersion systems. J. Pharm. Sci., 60, 1281–1302 (1971).

    Article  PubMed  CAS  Google Scholar 

  • Craig, D. Q., The mechanisms of drug release from solid dispersions in water-soluble polymers. Int. J. Pharm., 231, 131–144 (2002).

    Article  PubMed  CAS  Google Scholar 

  • Ford, J. L., The current status of solid dispersions. Pharm. Acta Helv., 61, 69–88 (1986).

    PubMed  CAS  Google Scholar 

  • Heo, M. Y., Piao, Z. Z., Kim, T. W., Cao, Q. R., Kim, A., and Lee, B. -J., Effect of solubilizing and microemulsifying excipients in polyethylene glycol 6000 solid dispersion on enhanced dissolution and bioavailability of ketoconazole. Arch. Pharm. Res., 28, 604–611 (2005).

    Article  PubMed  CAS  Google Scholar 

  • Kai, T., Akiyama, Y., Nomura, S., and Sato, M., Oral absorption improvement of poorly soluble drug using solid dispersion technique. Chem. Pharm. Bull., 44, 568–571 (1996).

    PubMed  CAS  Google Scholar 

  • Lengeling, R. W., Mitros, F. A., Brennan, J. A., and Schulze, K. S., Ulcerative ileitis encountered at ileo-colonoscopy: likely role of nonsteroidal agents. Clin. Gastroenterol. Hepatol., 1, 160–169 (2003).

    Article  PubMed  CAS  Google Scholar 

  • Leuner, C. and Dressman, J., Improving drug solubility for oral delivery using solid dispersions. Eur. J. Pharm. Biopharm., 50, 47–60 (2000).

    Article  PubMed  CAS  Google Scholar 

  • Pillay, V. and Fassihi, R., Electrolyte-induced compositional heterogeneity: a novel approach for rate-controlled oral drug delivery. J. Pharm. Sci., 88, 1140–1148 (1999).

    Article  PubMed  CAS  Google Scholar 

  • Riis, T., Bauer-Brandl, A., Wagner, T., and Kranz, H., pHindependent drug release of an extremely poorly soluble weakly acidic drug from multiparticulate extended release formulations. Eur. J. Pharm. Biopharm., 65, 78–84 (2007).

    Article  PubMed  CAS  Google Scholar 

  • Siepe, S., Lueckel, B., Kramer, A., Ries, A., and Gurny, R., Strategies for the design of hydrophilic matrix tablets with controlled microenvironmental pH. Int. J. Pharm., 316, 14–20 (2006).

    Article  PubMed  CAS  Google Scholar 

  • Streubel, A., Siepmann, J., Dashevsky, A., and Bodmeier, R., pH-independent release of a weakly basic drug from water-insoluble and -soluble matrix tablets. J. Control. Release, 67, 101–110 (2000).

    Article  PubMed  CAS  Google Scholar 

  • Tran, P. H. L., Tran, H. T. T., and Lee, B.-J., Modulation of microenvironmental pH and crystallinity of ionizable telmisartan using alkalizers in solid dispersions for controlled release. J. Control. Release, 129, 59–65 (2008).

    Article  PubMed  CAS  Google Scholar 

  • Tran, T. T.-D., Tran, P. H.-L., and Lee, B.-J., Dissolutionmodulating mechanism of alkalizers and polymers in nanoemulsifying solid dispersion containing ionizable and poorly water-soluble drug. Eur. J. Pharm. Biopharm., 72, 83–90 (2009).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Beom-Jin Lee.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Phuong, HL.T., Tran, T.TD., Lee, S.A. et al. Roles of MgO release from polyethylene glycol 6000-based solid dispersions on microenvironmental pH, enhanced dissolution and reduced gastrointestinal damage of telmisartan. Arch. Pharm. Res. 34, 747–755 (2011). https://doi.org/10.1007/s12272-011-0508-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12272-011-0508-2

Key words

Navigation